Abstract
Abstract
Purpose
To ensure high-quality screening programmes and effective utilization of resources, it is important to monitor how cancer detection is affected by different strategies performed at recall assessment. This study aimed to describe procedures performed at recall assessment and compare and evaluate the performance of the assessment in Denmark, Norway, and Spain in terms of screen-detected cancer (SDC) and interval cancer (IC) rates.
Methods
We included women aged 50–69 years from Denmark, Norway, and Spain, who were recalled for assessment after screening mammography, and recorded all procedures performed during six months after diagnosis, and the timing of the procedures. Women were followed for two years and screen-detected and interval cancer, and sensitivity of recall was calculated and compared.
Results
In total, data from 24,645 Danish, 30,050 Norwegian, and 41,809 Spanish women were included in the study. Most of the women had some assessment within 2 months in all three countries. SDC rates were higher in Denmark (0.57) and Norway (0.60) compared to Spain (0.38), as were the IC rates, i.e. 0.25 and 0.18 vs. 0.12, respectively. The sensitivity of the diagnostic follow-up was somewhat higher in Denmark (98.3%) and Norway (98.2%), compared to Spain (95.4%), but when excluding non-invasive assessment pathways, the sensitivities were comparable.
Conclusion
This comparison study showed variation in the assessment procedures used in the three countries as well as the SDC and IC rates and the sensitivity of recall.
Funder
University of Southern Denmark
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Altobelli E, Lattanzi A (2014) Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol 45(5):1785–1792
2. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, et al. (2006) European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edn, p 416
3. Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, Kan L et al (2002) Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94(8):2143–2150
4. Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, et al. (2018) Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium. CA: A Cancer Journal for Clinicians
5. Hafslund B, Nortvedt MW (2009) Mammography screening from the perspective of quality of life: a review of the literature. Scand J Caring Sci 23(3):539–548